ClinicalTrials.Veeva

Menu
N

Neuroscience Research Institute | West Palm Beach, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BHV-7000
ACP-204
Aticaprant
KarXT
Centanafadine
Esketamine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

The primary purpose of this trial is to evaluate the safety and tolerability of centanafadine QD XR in pediatric subjects with ADHD.

Active, not recruiting
Attention Deficit/Hyperactivity Disorder
Drug: Centanafadine Hydrochloride
Locations recently updated

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...

Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204

The purpose of this study is to determine the efficacy and safety of BHV-7000 in participants with Major Depressive Disorder (MDD)

Active, not recruiting
Major Depressive Disorder
Drug: BHV-7000
Drug: Placebo

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).

Invitation-only
Major Depressive Disorder
Drug: BHV-7000

Trial sponsors

Biohaven logo
Janssen (J&J Innovative Medicine) logo
Acadia Pharmaceuticals logo
Karuna Therapeutics logo
Otsuka logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems